NCT03562273 2026-02-20
GCC 1876
University of Maryland, Baltimore
Recruiting
Clinical Trials
21 trialsNCT07242118 2026-02-10
CARMEN
University of Kansas Medical Center
Phase NA Recruiting
NCT07120100 2025-11-21
rTMS for CIPN
University of Utah
Phase NA Recruiting
NCT03342625 2025-10-02
BRIFU
Institut Bergonié
Phase NA Recruiting
NCT05259410 2025-10-01
Time Restricted Eating During Chemotherapy for Breast Cancer
University of Illinois at Chicago
Phase NA Recruiting
NCT05116449 2025-09-17
IDSein
Ramsay Générale de Santé
Recruiting
NCT03797482 2025-09-10
Hypoxia
Tata Memorial Hospital
Recruiting
NCT05676255 2025-07-30
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
University of Arizona
Phase 2 Recruiting
NCT04504747 2025-06-15
NEO-R
Institut Paoli-Calmettes
Recruiting
NCT03144648 2025-05-06
PRECAMA
International Agency for Research on Cancer
Recruiting
NCT05460780 2025-03-20
TIDE
Quanta Medical
Phase NA Recruiting
NCT06035679 2025-03-12
Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
First Affiliated Hospital of Fujian Medical University
Phase NA Recruiting
NCT04133077 2025-02-13
XenoBreast
Centre Jean Perrin
Phase NA Recruiting
NCT06636591 2024-11-15
Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer
Fudan University
Phase NA Recruiting
NCT04767659 2024-09-19
Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging
IRCCS San Raffaele
Phase NA Recruiting
NCT06555614 2024-08-15
ADM
DOF Inc.
Recruiting
NCT06555692 2024-08-15
SCderm
DOF Inc.
Recruiting
NCT06553859 2024-08-14
SCderm
DOF Inc.
Recruiting
NCT05730608 2024-05-09
18F-FDG PET/CT Imaging for Breast Cancer
Vestre Viken Hospital Trust
Phase NA Recruiting
NCT05914831 2023-07-03
Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)
Oncology Institute of Vojvodina
Phase 2 Recruiting
NCT05314114 2022-04-18
Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT
Peking University
Phase NA Recruiting